Magic mushroom compound could ease bipolar depression in new trial
NCT ID NCT06943573
First seen May 03, 2026 · Last updated May 19, 2026 · Updated 4 times
Summary
This study tests whether a single dose of psilocybin (25 mg), given with therapy, can reduce depression in people with bipolar II disorder who haven't gotten better with standard treatments. About 90 adults aged 19-65 will receive either the full dose or a very low placebo dose, and their symptoms will be tracked for 12 weeks. The goal is to see if this approach is safe and effective for easing depression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR II DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Psychiatry, University of Ottawa, The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Psychiatry, University of Toronto, University Health Network,
Toronto, Ontario, M5T 2S8, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Djavad Mowafaghian Centre for Brain Health
Vancouver, British Columbia, V6T 1Z3, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.